NCT06483945

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 5,000 (estimated)
• Sponsor: DexCom, Inc. · Industry
• Sex: All
• Age: 2 Years
• Healthy volunteers: Accepted

Summary

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Detailed description

"The Dexcom Global Registry is a non-randomized, open-label, multi-center registry with the goal of collecting Dexcom CGM System data in a real world setting.The registry study involves retrospective and/or prospective data collection associated with Dexcom CGM System use."

Conditions

• Diabetes

Interventions

Type	Name	Description
DEVICE	Dexcom CGM G6/G6 Pro/G7	Dexcom CGM G6/G6 Pro/G7 device

Timeline

• Start date: 2024-02-28
• Primary completion: 2028-03-31
• Completion: 2028-06-30
• First posted: 2024-07-03
• Last updated: 2024-07-03

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated device study